Pharmacy & Biological SciencesCategory
How a proposed tax penalty on drugs with price increases exceeding the inflation could impact patients, public insurance programs, and innovation.
Researchers found nearly a third of approvals from 2001 through 2010 had major safety issues years after they were widely available to patients.
Managing post-op pain is a team effort—and who better to lead the team than a medication expert?
The arrival of Radicava for ALS marks the first new drug in the market for this rare disease since 1995.
Congress grants the National Institutes of Health a $2 billion raise.
The incidence of diabetes is 17% higher in rural areas than it is in cities.
In March, Idaho passed the first law in the U.S. allowing pharmacy technicians to administer immunizations.
From a $1.2M gene therapy to a $450K lymphoma med, these are the 10 priciest medications out there.
The possibility of curing sepsis with a common vitamin has put one of history’s greatest killers back in the spotlight.
Scientists invented chemical weapons; some are now working to destroy them.